menu
    • menu

    Company profile for Capsida

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a biotechnology company creating a new class of targeted gene therapies for debilitating and life-threatening genetic disorders in both central nervous system (CNS) and non-CNS indications. Current gene therapy approaches have shown dramatic efficacy in several rare diseases but are hindered by imprecise targeting. The inability to selectively transduce specific cells and tissues effectively drives administration of hig...
    We are a biotechnology company creating a new class of targeted gene therapies for debilitating and life-threatening genetic disorders in both central nervous system (CNS) and non-CNS indications. Current gene therapy approaches have shown dramatic efficacy in several rare diseases but are hindered by imprecise targeting. The inability to selectively transduce specific cells and tissues effectively drives administration of higher doses and resulting safety liabilities. We are addressing these concerns with our proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CapsidaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1290 Rancho Conejo Blvd, Newbury Park, CA 91320
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://capsida.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/capsida-biotherapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Capsida Announces Patient Death in Gene Therapy Trial
    Capsida Announces Patient Death in Gene Therapy Trial

    11 Sep 2025

    // BIOSPACE

    https://www.biospace.com/drug-development/capsida-reports-patient-death-in-gene-therapy-trial

    BIOSPACE
    11 Sep 2025
    Share Share
    Capsida Gets FDA IND Clearance for IV Gene Therapy in Parkinson
    Capsida Gets FDA IND Clearance for IV Gene Therapy in Parkinson

    11 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250611109903/en/Capsida-Receives-FDA-IND-Clearance-for-Its-IV-Administered-Gene-Therapy-for-Parkinsons-Disease-Associated-With-GBA-Mutations

    BUSINESSWIRE
    11 Jun 2025
    Share Share
    Capsida's IV Gene Therapy for STXBP1 Epilepsy Gets FDA Fast Track
    Capsida's IV Gene Therapy for STXBP1 Epilepsy Gets FDA Fast Track

    29 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250529358091/en/Capsida-Receives-FDA-Fast-Track-Designation-for-Its-Potential-First-in-Class-IV-Administered-Gene-Therapy-for-STXBP1-Developmental-and-Epileptic-Encephalopathy

    BUSINESSWIRE
    29 May 2025
    Share Share
    Capsida Reveals Data Supporting IND for STXBP1 Gene Therapy
    Capsida Reveals Data Supporting IND for STXBP1 Gene Therapy

    14 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250514208408/en/Capsida-Presents-New-GLP-Toxicology-Data-Supporting-Recent-FDA-IND-Clearance-of-Its-First-in-Class-IV-administered-Gene-Therapy-for-STXBP1-Developmental-and-Epileptic-Encephalopathy

    BUSINESSWIRE
    14 May 2025
    Share Share
    Capsida Gets IND OK for STXBP1 Gene Therapy Trial
    Capsida Gets IND OK for STXBP1 Gene Therapy Trial

    12 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250512366164/en/Capsida-Receives-FDA-IND-Clearance-for-Its-First-in-Class-IV-administered-Gene-Therapy-for-STXBP1-Developmental-and-Epileptic-Encephalopathy

    BUSINESSWIRE
    12 May 2025
    Share Share
    Capsida to Share NHP Tox Data for STXBP1-DEE at ASGCT
    Capsida to Share NHP Tox Data for STXBP1-DEE at ASGCT

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428763273/en/Capsida-to-Present-Progress-Updates-at-the-ASGCT-Annual-Meeting-Including-NHP-GLP-Toxicology-Study-Results-for-its-Potential-First-in-Class-STXBP1-Developmental-and-Epileptic-Encephalopathy-Program-CAP-002-STXBP1-DEE

    BUSINESSWIRE
    28 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search